Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

ClinicalTrials.gov ID: NCT04750902

Public ClinicalTrials.gov record NCT04750902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Active-controlled Multi-center Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices With 1.5%, 4.0% and 8.0% Arginine Each in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

Study identification

NCT ID
NCT04750902
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Colgate Palmolive
Industry
Enrollment
2,025 participants

Conditions and interventions

Conditions

Interventions

  • 0.24% Sodium Fluoride Dentifrice Drug
  • 1.5% Arginine Dentifrice Drug
  • 4.0% Arginine Dentifrice Drug
  • 8.0% Arginine Dentifrice Drug

Drug

Eligibility (public fields only)

Age range
10 Years to 14 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2021
Primary completion
Feb 27, 2024
Completion
Feb 27, 2024
Last update posted
Jul 20, 2026

2021 – 2024

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Loma Linda University School of Dentistry Loma Linda California 92350
University of Florida College of Dentistry Gainesville Florida 32610
Indiana University School of Dentistry Indianapolis Indiana 46202-2876
Tufts University School of Dental Medicine Boston Massachusetts 02111
The Forsyth Institute Boston Massachusetts 02142
University at Buffalo School of Dental Medicine Buffalo New York 14214
University of Pennsylvania School of Dental Medicine Philadelphia Pennsylvania 19104-6003
UT Health San Antonio School of Dentistry San Antonio Texas 78229-3900

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04750902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2026 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04750902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →